[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-352713-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-352713-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","ermp1-exerts-tumor-suppressive-functions-in-kirc-inhibiting-pi3kakt-signaling-and-remodeling-the-immune-microenvironment-a-pan-cancer-analysis","ERMP1 Exerts Tumor-Suppressive Functions in KIRC - Inhibiting PI3K/AKT Signaling and Remodeling the Immune Microenvironment - A Pan-Cancer Analysis","","Kidney renal clear cell carcinoma (KIRC) is an aggressive cancer with limited treatment options, motivating discovery of biomarkers and therapeutic targets. This study evaluates ERMP1 as a potential tumor-suppressive factor by integrating TCGA, GTEx, and GEO data for pan-cancer expression, genomic alterations, and prognosis. Single-cell transcriptomics defines ERMP1 cell-type enrichment in the tumor immune microenvironment. ERMP1 overexpression in KIRC models suppresses proliferation, migration, invasion, and clonogenic capacity, while mechanistic assays link its effects to PI3K/AKT inhibition, EMT modulation, and reduced invasion- and cell-cycle proteins, supported by xenograft tumor growth inhibition.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/ermp1-exerts-tumor-suppressive-functions-in-kirc-inhibiting-pi3kakt-signaling-and-remodeling-the-immune-microenvironment-a-pan-cancer-analysis/352713/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/ermp1-exerts-tumor-suppressive-functions-in-kirc-inhibiting-pi3kakt-signaling-and-remodeling-the-immune-microenvironment-a-pan-cancer-analysis/352713.png","ImageObject",300,407,{"name":42,"@type":43},"Aria Callaghan","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role does ERMP1 play in KIRC according to this study?","Question",{"text":63,"@type":64},"ERMP1 exhibits tumor-suppressive functions in KIRC, where higher expression predicts a favorable prognosis and correlates negatively with advanced pathological features.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was ERMP1 evaluated across cancers in this research?",{"text":68,"@type":64},"The study integrates TCGA, GTEx, and GEO datasets for expression patterns, genetic alterations, and prognostic value, complemented by single-cell transcriptomic analyses within the tumor immune microenvironment.",{"name":70,"@type":61,"acceptedAnswer":71},"What mechanisms connect ERMP1 to reduced tumor aggressiveness?",{"text":72,"@type":64},"ERMP1 inhibits the PI3K/AKT signaling pathway, modulates epithelial-mesenchymal transition (E-cadherin upregulation and N-cadherin downregulation), and decreases invasion- and cell cycle-related proteins such as MMP2/MMP9 and Cyclin D1/CDK4.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},352713,1790184595,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":99,"preview_page_count":33,"preview_urls":145},962084926284,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Human Mutation  \n SPECIAL ISSUE  Variant-to-Biomarker: Multi-omics Integration for Interpreting Human Genetic Variation and Clinical Translation  \nRESEARCH ARTICLE  OPEN ACCESS   \nERMP1 Exerts Tumor-Suppressive Functions in KIRC by Inhibiting PI3K/AKT Signaling and Remodeling the Immune Microenvironment: A Pan-Cancer Analysis  \nZiyang Liu1 | Jiahao Shan1 | Tao Yang2 | Qiang Zhang2 | Lianghong Ma2 | Feilong Yang2  \n1First Clinical Medical College, Ningxia Medical University, Yinchuan, Ningxia, China | 2Department of Urology, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China  \nCorrespondence: Lianghong Ma ([mmm1770@163.com](mmm1770@163.com)) | Feilong Yang ([904100144@qq.com](904100144@qq.com))  \nReceived: 12 November 2025 | Revised: 6 January 2026 | Accepted: 12 January 2026  \nGuest Editor: Hao Chi  \nKeywords: ERMP1 | kidney renal clear cell carcinoma (kirc) | PI3K/AKT signaling pathway | tumor microenvironment | tumor suppressor  \nABSTRACT  \nBackground: Kidney renal clear cell carcinoma (KIRC) is an aggressive malignancy with limited therapeutic options, highlighting the need for novel biomarkers and therapeutic targets. Although endoplasmic reticulum metallopeptidase 1 (ERMP1) has been implicated in cancer progression, its specific role, clinical significance, and underlying mechanisms in KIRC remain poorly defined.  \nMethods: We integrated data from the TCGA, GTEx, and GEO databases to conduct a pan-cancer analysis, aiming to systematically evaluate the expression patterns, genetic alterations, and prognostic value of ERMP1 . Single-cell transcriptomic data were utilized to decipher its cell-type–specific expression within the tumor immune microenvironment. By establishing ERMP1 overexpression models in KIRC cell lines (Caki-1 and A498), we assessed its impact on malignant phenotypes using CCK-8, colony formation, transwell, and wound healing assays. The underlying mechanisms were further investigated via Western blotting. Finally, by establishing a xenograft tumor model in vivo, we evaluated the inhibitory effect of ERMP1 on tumor growth ofKIRC in vivo.  \nResults: The prognostic value of ERMP1 exhibits cancer type-specificity. In KIRC, its high expression serves as an independent marker for favorable prognosis and is negatively correlated with advanced pathological features. Single-cell analysis revealed that ERMP1 is enriched in regulatory T cells and proliferative exhausted T cells. Its high expression is closely associated with an immunologically activated tumor microenvironment, characterized by upregulation of immunostimulatory factors and chemokines, alongside increased lymphocyte infiltration. Functionally, ERMP1 overexpression significantly suppressed the proliferation, migration, invasion, and clonogenic ability of KIRC cells. Mechanistically, ERMP1 inhibits the PI3K/AKT signaling pathway, impedes epithelial-mesenchymal transition (manifested as E-cadherin upregulation and N-cadherin downregulation), and reduces the expression of invasion-related proteins (MMP2 and MMP9) and cell cycle-related proteins (Cyclin D1 and CDK4) . In vivo xenograft tumor assays confirmed that ERMP1 overexpression could significantly inhibit tumor growth.  \nConclusion: This study confirms that ERMP1 exhibits significant potential in tumorigenesis, diagnosis, prognosis, and regulation of the tumor microenvironment (TME). In KIRC, ERMP1 may exert tumor-suppressive effects by inhibiting the PI3K/AKT signaling pathway and regulating immune responses, thus representing a potential prognostic biomarker and therapeutic target.  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \nCopyright © 2026 Ziyang Liu et al. Human Mutation published by John Wiley & Sons Ltd.  \nHuman Mutation, 2026; 2026:7717815 1 of 24  \n[https://doi.org/10.1155/humu/7717815](https://doi.org/10.1155/h","cbCaiemGNBqWiQV2","https://ap.wps.com/l/cbCaiemGNBqWiQV2","pdf",10677862,24,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What role does ERMP1 play in KIRC according to this study?\",\"answer\":\"ERMP1 exhibits tumor-suppressive functions in KIRC, where higher expression predicts a favorable prognosis and correlates negatively with advanced pathological features.\"},{\"question\":\"How was ERMP1 evaluated across cancers in this research?\",\"answer\":\"The study integrates TCGA, GTEx, and GEO datasets for expression patterns, genetic alterations, and prognostic value, complemented by single-cell transcriptomic analyses within the tumor immune microenvironment.\"},{\"question\":\"What mechanisms connect ERMP1 to reduced tumor aggressiveness?\",\"answer\":\"ERMP1 inhibits the PI3K/AKT signaling pathway, modulates epithelial-mesenchymal transition (E-cadherin upregulation and N-cadherin downregulation), and decreases invasion- and cell cycle-related proteins such as MMP2/MMP9 and Cyclin D1/CDK4.\"}]","ERMP1 Exerts Tumor-Suppressive Functions in KIRC - Inhibiting PI3K/AKT Signaling and Remodeling the Immune Microenvironment - A Pan-Cancer Analysis | PDF",1790101077,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c1a463a48ee50c5c30ab9502ff8249df.webp",983,1291,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ff605b74c7121a316fc82676525ff99a.webp",982,1290,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8db64903948d07e02464fabb28650094.webp",981,1289,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/97ecd89db77856a971929b71b68706f5.webp",980,1287]